TiamulinCAS# 55297-95-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 55297-95-5 | SDF | Download SDF |
| PubChem ID | 656958 | Appearance | Powder |
| Formula | C28H47NO4S | M.Wt | 493.7 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C | ||
| Standard InChIKey | UURAUHCOJAIIRQ-QGLSALSOSA-N | ||
| Standard InChI | InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27+,28+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Tiamulin Dilution Calculator
Tiamulin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.0255 mL | 10.1276 mL | 20.2552 mL | 40.5104 mL | 50.638 mL |
| 5 mM | 0.4051 mL | 2.0255 mL | 4.051 mL | 8.1021 mL | 10.1276 mL |
| 10 mM | 0.2026 mL | 1.0128 mL | 2.0255 mL | 4.051 mL | 5.0638 mL |
| 50 mM | 0.0405 mL | 0.2026 mL | 0.4051 mL | 0.8102 mL | 1.0128 mL |
| 100 mM | 0.0203 mL | 0.1013 mL | 0.2026 mL | 0.4051 mL | 0.5064 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (Z)-Falcarindiol
Catalog No.:BCN8495
CAS No.:55297-87-5
- Atractylodin
Catalog No.:BCN6292
CAS No.:55290-63-6
- Praziquantel
Catalog No.:BCC4829
CAS No.:55268-74-1
- MnTBAP Chloride
Catalog No.:BCC6477
CAS No.:55266-18-7
- Boc-Gln(Xan)-OH
Catalog No.:BCC3385
CAS No.:55260-24-7
- A-674563
Catalog No.:BCC3903
CAS No.:552325-73-2
- A-443654
Catalog No.:BCC1321
CAS No.:552325-16-3
- T16Ainh - A01
Catalog No.:BCC6220
CAS No.:552309-42-9
- Vallesiachotamine
Catalog No.:BCN3548
CAS No.:5523-37-5
- Rolapitant
Catalog No.:BCC6441
CAS No.:552292-08-7
- AP 18
Catalog No.:BCC7634
CAS No.:55224-94-7
- Dexamethasone Sodium Phosphate
Catalog No.:BCC4557
CAS No.:55203-24-2
- Thonzonium Bromide
Catalog No.:BCC5636
CAS No.:553-08-2
- Xanthyletin
Catalog No.:BCN6722
CAS No.:553-19-5
- Costunolide
Catalog No.:BCN5740
CAS No.:553-21-9
- Atherosperminine
Catalog No.:BCN8208
CAS No.:5531-98-6
- Soyasaponin II
Catalog No.:BCN1418
CAS No.:55319-36-3
- Petasiphenone
Catalog No.:BCC8100
CAS No.:162616-81-1
- Beclomethasone dipropionate
Catalog No.:BCC4257
CAS No.:5534-09-8
- Vidarabine
Catalog No.:BCC4877
CAS No.:5536-17-4
- Baohuoside II
Catalog No.:BCN2888
CAS No.:55395-07-8
- Hydroxyisoleucine
Catalog No.:BCN8402
CAS No.:55399-93-4
- Lithium carbonate
Catalog No.:BCC7970
CAS No.:554-13-2
- Methazolamide
Catalog No.:BCC2318
CAS No.:554-57-4
Antimicrobial Susceptibility Profile of Enterococcus Species Isolated from Companion Birds and Poultry in the Northeast of Iran.[Pubmed:30280840]
Arch Razi Inst. 2018 Sep;73(3):207-213.
Enterococci are Gram-positive facultative anaerobic bacteria commonly found in the gastrointestinal tract of the mammals and birds. These cocci are isolated from urinary tract infections, bacteremia, endocarditis, and burn wounds in humans. The evolution of antibiotic-resistant enterococci raised a problem due to the possibility of the transmission of these organisms between poultry and human. Regarding this, the present study was conducted to evaluate the prevalence of Enterococcus species among companion birds and poultry in the Northeastern of Iran and determine the antibiotic susceptibility profile of enterococci. To this end, oral and cloacal swabs were collected from 150 caged birds. Antibiotic susceptibility profile was determined using the standard disk diffusion method. The results revealed that out of 150 samples, 56 (37.33%) cases contained enterococci. Most of the specimens (25.33%) were Enterococcus faecalis isolated from 6.66% of the samples. Additionally, 2.66% and 1.33% of the samples were contaminated with Enterococcus mundtii and Enterococcus gallinarum, respectively. Furthermore, Enterococcus malodoratus and Enterococcus raffinosus were isolated from 0.66% of the samples. The results revealed that all of the isolates of E. faecalis and E. faecium were resistant to more than five antimicrobial agents. Most of E. faecalis and E. faecium isolates showed resistance to Cefazolin, Tiamulin, Flumequine, and Cephalexin. Accordingly, the majority of the isolates had multidrug resistance to the tested antibiotics. In conclusion, the presence of multidrug-resistant enterococci in the birds living close to humans requires thorough observations due to the transmission of these organisms to humans.
